Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX4 | Q9NPH5 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 7/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.74 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.74 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.74 |
| ▸ | IPMK | Q8NFU5 | 3/20 | 0.74 |
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.74 |
| ▸ | XDH | P47989 | 3/20 | 0.74 |
| ▸ | CA12 | O43570 | 2/20 | 0.74 |
| ▸ | CA2 | P00918 | 2/20 | 0.74 |
| ▸ | CA4 | P22748 | 2/20 | 0.74 |
| ▸ | PPARG | P37231 | 2/20 | 0.74 |
| ▸ | CA7 | P43166 | 2/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | MAPT | P10636 | 5/20 | 0.72 |
| ▸ | RECQL | P46063 | 4/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31408172 | 1.00 | NOX4 (1.00) | NOX4MEN1KMT2ACYP1A2CYP1A1 | |
| SCHEMBL29929374 | 1.00 | NOX4 (1.00) | NOX4MEN1KMT2ACYP1A2CYP1A1 | |
| SCHEMBL29442903 | 0.93 | MEN1 (0.86) | NOX4MEN1KMT2ACYP1A2CYP1A1 | |
| SCHEMBL27693769 | 0.90 | NOX4 (0.81) | NOX4MEN1KMT2ACYP1A2CYP1A1 | |
| Isorhamnetin SCHEMBL3715283 | 0.89 | MEN1 (0.93) | NOX4MEN1KMT2ACYP1A2CYP1A1 | |
| SCHEMBL31304741 | 0.89 | POLB (0.82) | NOX4MEN1KMT2AXDHKDM4E | |
| SCHEMBL30284949 | 0.89 | POLB (0.82) | NOX4MEN1KMT2AXDHKDM4E | |
| SCHEMBL11149169 | 0.89 | POLB (0.82) | NOX4MEN1KMT2AXDHKDM4E | |
| SCHEMBL26936149 | 0.89 | KDM4E (0.82) | NOX4MEN1KMT2ACYP1A2CYP1A1 | |
| SCHEMBL15635189 | 0.88 | NOX4 (0.79) | NOX4MEN1KMT2ACYP1A2CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| WO-2025235852-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-13 | — | — | WO | claimed |
| WO-2025038482-A2 | USE OF FISETIN FOR REDUCING THE INCIDENCE OF ATRIAL FIBRILLATION | RHODE ISLAND HOSPITAL (US) | 2025-02-20 | — | — | WO | claimed |
| US-20250009892-A1 | DELIVERY SYSTEMS AND METHODS FOR REACTIVE HYDROXYL-CONTAINING COMPOUNDS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2025-01-09 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| US-11560342-B2 | Bacillus isolates and uses thereof | MONSANTO TECHNOLOGY, LLC (US) | 2023-01-24 | — | — | US | claimed |
| WO-2022194862-A1 | METHOD FOR PREDICTING THE LIKELIHOOD OF PREGNANCY IN FEMALE MAMMALS WHICH EXPERIENCE AN ESTROUS CYCLE | BREEDSENSE AS (NO) | 2022-09-22 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| EP-2755499-A1 | QUERCETIN FOR BROWNING FOOD SURFACES | Nestec S.A. (CH) | 2014-07-23 | — | — | EP | claimed |
| EP-2736484-A1 | BOTANICAL ANTIOXIDANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | US CosmeceuTechs LLC (US) | 2014-06-04 | — | — | EP | claimed |
| US-8642087-B1 | Compounds and methods for reducing oxidative stress | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-02-04 | — | — | US | claimed |
| EP-2665467-A2 | FLAVONOL COMPOSITIONS | Ono, Mitsunori (US) | 2013-11-27 | — | — | EP | claimed |
| WO-2013037603-A1 | QUERCETIN FOR BROWNING FOOD SURFACES | NESTEC S.A. (CH) | 2013-03-21 | — | — | WO | claimed |
| WO-2013016257-A1 | BOTANICAL ANTIOXIDANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | US COSMECEU TECHS LLC (US) | 2013-01-31 | — | — | WO | claimed |
| US-20120208118-A1 | RESIN COMPOSITIONS AND PROCESSES | XEROX CORPORATION (US) | 2012-08-16 | — | — | US | claimed |
| WO-2012099930-A2 | FLAVONOL COMPOSITIONS | ONO MITSUNORI (US) | 2012-07-26 | — | — | WO | claimed |
| US-20120183587-A1 | FLAVONOL COMPOSITIONS | LINES, THOMAS CHRISTIAN (CH) | 2012-07-19 | — | — | US | claimed |
| CN-101119719-A | The use of flavonol and flavonol glycosides for stimulating growth of renal tubular epithelial cells to secrete the kidney secreting bone growth factor | MIAN LONG (US) | 2008-02-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | NOX4 3675/4885MEN1 1711/4885KMT2A 4742/4885 |
| US-20120183587-A1 | FLAVONOL COMPOSITIONS | CYP2F1, F3, TEAD3 | NOX4 3973/4885MEN1 2383/4885KMT2A 2991/4885 |
| US-11560342-B2 | Bacillus isolates and uses thereof | BLVRB, BROX, GLB1 | NOX4 3145/4885MEN1 3424/4885KMT2A 4261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.